Diabetes complications

Circulating Adipocyte Fatty Acid-binding Protein (AFABP), FGF21, and Pigment Epithelium-derived Factor (PEDF) Levels as Prognostic Biomarkers of Sight-threatening Diabetic Retinopathy

J Clin Endocrinol MetabPublished Prospective cohort study

Authors' conclusion

Among the 3 diabetes-related biomarkers, serum AFABP level appeared to be a more clinically useful biomarker for predicting incident STDR in type 2 diabetes.

Study context

Population
Chinese individuals with T2D without sight-threatening DR (STDR) at baseline; mean diabetes duration 11 years, ≥ 50% with nonproliferative DR at baseline172 developed STDR
Participants
4,760 individuals
Exposure
Baseline serum AFABP, FGF21 and PEDF levels as predictors of incident STDR
Outcome
Incident sight-threatening DR (STDR)
Follow-up
Median 8.8 years

Main finding

As reported in the abstract

Incident STDR · median follow-up 8.8 years

Serum AFABP independently associated with incident STDR, multivariable Cox regression

1.28

HR; 95% CI 1.05–1.55P = .013

Observational data: associations, not effects.

Further findings

Addition of serum AFABP to clinical model (diabetes duration, glycemic control, albuminuria, baseline DR status), participants without DR or with mild DR at baseline

Improved c statistics
P < 0.001
Improved net reclassification index
P = 0.0027
Improved integrated discrimination index
P = 0.033

Original publication

Circulating AFABP, FGF21, and PEDF Levels as Prognostic Biomarkers of Sight-threatening Diabetic Retinopathy. J Clin Endocrinol Metab. Published 28 February 2023. doi:10.1210/clinem/dgad112

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.